Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
6,2 USD | +0,73% | 0,00% | -8,15% |
Attività
Numero di dipendenti: 76
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100,0
%
| 6 | 100,0 % | 3 | 100,0 % | -55,77% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 6 | 100,0 % | 3 | 100,0 % | -55,77% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Alexander Sapir
CEO | Chief Executive Officer | 57 | 01/07/23 |
Alan Musso
DFI | Director of Finance/CFO | 62 | 07/08/23 |
Chief Tech/Sci/R&D Officer | - | 01/07/21 | |
Leslie Leinwand
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 01/12/22 | |
Robert Gould
BRD | Director/Board Member | 69 | - |
Iain Fraser
PRN | Corporate Officer/Principal | - | 01/03/23 |
Kristina Storey
LAW | General Counsel | - | 01/11/22 |
Paul Bruno
PRN | Corporate Officer/Principal | - | 01/01/19 |
Comptroller/Controller/Auditor | - | 11/03/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
James Geraghty
BRD | Director/Board Member | 69 | 19/07/16 |
Director/Board Member | 70 | 01/12/16 | |
James Collins
BRD | Director/Board Member | 58 | 01/01/17 |
Robert Gould
BRD | Director/Board Member | 69 | - |
Kathryn Haviland
CHM | Chairman | 48 | 27/06/18 |
Katina Dorton
BRD | Director/Board Member | 66 | 02/01/20 |
Alexander Sapir
CEO | Chief Executive Officer | 57 | 01/07/23 |
Sonja Banks
BRD | Director/Board Member | 55 | 08/12/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 62 153 638 | 61 292 675 ( 98,61 %) | 0 | 98,61 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-8,15% | 385 Mln | |
+18,97% | 45,34 Mrd | |
+41,98% | 40,42 Mrd | |
-10,06% | 37,92 Mrd | |
+31,15% | 31,75 Mrd | |
-7,79% | 27,71 Mrd | |
+13,32% | 26,52 Mrd | |
+43,05% | 13,96 Mrd | |
+31,28% | 12,44 Mrd | |
-7,41% | 11,26 Mrd |
- Borsa valori
- Azioni
- Azione FULC
- Società Fulcrum Therapeutics, Inc.